Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.31 |
| ▸ | SELE | P16581 | 1/20 | 0.31 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3784658 | 0.78 | ALDH1A1 (0.37) | GAAMAPK1MAPTHTTHSD17B10 | |
| SCHEMBL3789223 | 0.73 | GAA (0.46) | GAAMAPK1MAPTHTTHSD17B10 | |
| SCHEMBL3782240 | 0.72 | ALDH1A1 (0.34) | GAAMAPTHSD17B10ALOX15ALDH1A1 | |
| SCHEMBL22789253 | 0.70 | GAA (0.38) | GAAMAPK1MAPTHTTHSD17B10 | |
| Hydrochloric Acid SCHEMBL22775101 | 0.68 | GAA (0.37) | GAAMAPK1MAPTHTTHSD17B10 | |
| SCHEMBL3790404 | 0.67 | ALDH1A1 (0.34) | GAAMAPK1HSD17B10ALDH1A1SELE | |
| SCHEMBL22789340 | 0.65 | MAPK1 (0.35) | GAAMAPK1MAPTHTTHSD17B10 | |
| SCHEMBL3788053 | 0.65 | MGLL (0.34) | MAPTALDH1A1 | |
| SCHEMBL26585026 | 0.64 | ALDH1A1 (0.39) | GAAMAPK1MAPTHSD17B10ALOX15 | |
| Hydrochloric Acid SCHEMBL22774722 | 0.64 | MAPK1 (0.34) | GAAMAPK1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-1914221-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | NISCH, BLVRB, BBOX1 | GAA 1755/4885MAPK1 4726/4885MAPT 3312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.